Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancer.

Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancer.

<h4>Background</h4>HER-2 is a prognostic and predictive marker, but as yet no technique is perfectly able to identify patients likely to benefit from HER-2 targeted therapies. We aimed to prospectively assess the added value of first-line co-testing by IHC, and multiplex ligation-depende...

Full description

Bibliographic Details
Main Authors: Chantal C H J Kuijpers, Cathy B Moelans, Henk-Jan van Slooten, Anja Horstman, John W J Hinrichs, Shaimaa Al-Janabi, Paul J van Diest, Mehdi Jiwa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24324739/pdf/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24324739/pdf/?tool=EBI

Similar Items